Javascript is disabled or is not supported by your browser. Please upgrade your browser or enable Javascript to navigate the interface properly.

DeepCurrents Investment Group »

Sarepta Therapeutics Inc Note 1.250 9/1 shares owned by DeepCurrents Investment Group

Quarter-by-quarter ownership of Sarepta Therapeutics Inc Note 1.250 9/1 shares owned by DeepCurrents Investment Group from 13F filings

Historical chart of DeepCurrents Investment Group investment in Sarepta Therapeutics Inc Note 1.250 9/1

Tip: Access up to 7 years of quarterly data

All positions including Sarepta Therapeutics Inc Note 1.250 9/1 held by DeepCurrents Investment Group consolidated in one spreadsheet with up to 7 years of data

Download as csv

Download as Excel

Quarterly reported holdings in Sarepta Therapeutics Inc Note 1.250 9/1 by DeepCurrents Investment Group

Quarter filed	Position value	Share count	Share price at filing
2026-06-30	$16M	17M	0.94
2025-06-30	$38M	52M	0.74

More positions owned by DeepCurrents Investment Group

Spdr Gold Tr Gold Shs Call Option (GLD)

Ishares Bitcoin Trust Etf Shs Ben Int Put Option (IBIT)

Interdigital Note 3.500% 6/0 (Principal)

Select Sector Spdr Tr St Str Energ Etf Put Option (XLE)

Applied Digital Corp Note 2.750% 6/0 (Principal)

Alphabet Cap Stk Cl A Call Option (GOOGL)

Repligen Corp Note 1.000%12/1 (Principal)

MKS Note 1.250% 6/0 (Principal)

Snowflake Note 10/0 (Principal)

Bridgebio Pharma Note 2.500% 3/1 (Principal)

Cloudflare Note 8/1 (Principal)

Draftkings Note 3/1 (Principal)

Alignment Healthcare Note 4.250%11/1 (Principal)

Teladoc Health Note 1.250% 6/0 (Principal)

Xometry Note 0.750% 6/1 (Principal)

View all positions for DeepCurrents Investment Group

Top funds holding Sarepta Therapeutics Inc Note 1.250 9/1

Highbridge Capital Management

DeepCurrents Investment Group

D. E. Shaw & Co

LMR Partners

Calamos Advisors

Corbyn Investment Management

Oaktree Capital Management

Bnp Paribas Investment Partners

Russell Investments

FMR

Financial Consulate

Advent Capital Management

Jpmorgan Chase & Co

Morgan Stanley

HB Wealth Management

View all funds holding Sarepta Therapeutics Inc Note 1.250 9/1

Disclaimers: stockzoa.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on stockzoa.com represent a recommendation to purchase or sell a stock. The information on this site is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall stockzoa.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content available on stockzoa.com, or relating to the use of, or inability to use, stockzoa.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.

Fund Directory: 1-9 A B C D E F G H I J K L M N O P Q R S T U V W X-Z